FUJIFILM Diosynth Biotechnologies Unveils Global CDMO Ecosystem Expansion in Denmark
Introduction:
FUJIFILM Diosynth Biotechnologies is planning the first phase of its expansion at the Hillerød facility in Denmark.
Features:
The first phase of expansion will add six mammalian cell bioreactors, increasing the total capacity at the Hillerød site to 12 bioreactors, each with a capacity of 20,000 L.
This major investment will fund the next phase, which will add another eight 20,000 L bioreactors and two new downstream processing streams.
This expansion highlights the introduction of robust capabilities into the global biopharma sector, ensuring the timely delivery of critical therapies to those in need.
By mid-2025, fill/finish production is set to begin, with the full expansion expected to be operational by 2026. This will increase the site’s footprint to approximately 51,500m2 and create up to 2,200 jobs.
The Hillerød facility marks the first expansion in the global network, which will also see further developments in the US, UK, and Japan.
Specifications:
| Name : | FUJIFILM Diosynth Biotechnologies |
| Type : | New Construction |
| Year : | 2026 |
